Sign In  |  Register  |  About Daly City  |  Contact Us

Daly City, CA
September 01, 2020 1:20pm
7-Day Forecast | Traffic

  • Search Hotels in Daly City

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Quanterix Corp (NQ: QTRX )

12.49 +0.42 (+3.48%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 12, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Quanterix Corp

< Previous 1 2 3 4 Next >
Quanterix Corp. (NASDAQ: QTRX) is a Stock Spotlight on 8/21
Via Investor Brand Network
Quanterix Corp. (NASDAQ: QTRX) is a Stock Spotlight on 8/16
Via Investor Brand Network
Quanterix Appoints Vandana Sriram as Chief Financial Officer
From Quanterix Corporation
Via Business Wire
Quanterix Corp. (NASDAQ: QTRX) is a Stock Spotlight on 8/8
Via Investor Brand Network
Quanterix Releases Operating Results for Second Quarter 2023
From Quanterix Corporation
Via Business Wire
Quanterix to Present at Canaccord Genuity 43rd Annual Growth Conference
From Quanterix Corporation
Via Business Wire
Quanterix’s Simoa® Technology Powers Large, International Reference Range Study Utilizing Serum Neurofilament Light (sNfL) to Assess Neurological Disease Activity in Pediatric Patients
From Quanterix Corporation
Via Business Wire
Quanterix to Report Second Quarter 2023 Financial Results on August 8, 2023
From Quanterix Corporation
Via Business Wire
Quanterix Launches LucentAD Biomarker Blood Test to Aid Physician Diagnosis of Alzheimer’s Disease in Patients
From Quanterix Corporation
Via Business Wire
Quanterix to Participate in Fireside Chat at Goldman Sachs Annual Global Healthcare Conference
From Quanterix Corporation
Via Business Wire
Quanterix Releases Operating Results for First Quarter 2023
From Quanterix Corporation
Via Business Wire
Quanterix’s First Quarter 2023 Earnings Conference Call
From Quanterix Corporation
Via Business Wire
FDA Accelerated Approval of Tofersen Highlights Importance of Blood Neurofilament Light Chain as Surrogate Endpoint in Neurology Therapeutic Trials
From Quanterix Corporation
Via Business Wire
Quanterix to Participate in Barclays Global Healthcare Conference
From Quanterix Corporation
Via Business Wire
Quanterix Releases Operating Results for Fourth Quarter and Full Year 2022; Aligned with Expectations
From Quanterix Corporation
Via Business Wire
Quanterix to Present at Cowen’s 43rd Annual Health Care Conference
From Quanterix Corporation
Via Business Wire
Quanterix Fourth Quarter Earnings and Full Year 2022 Financial Results Conference Call
From Quanterix Corporation
Via Business Wire
Quanterix Announces Appointment of Brian Blaser to Board of Directors
From Quanterix Corporation
Via Business Wire
Quanterix Expands Laboratory Developed Test Menu with Launch of Neurofilament Light Chain Test
From Quanterix Corporation
Via Business Wire
Quanterix to Present at 41st Annual J.P. Morgan Healthcare Conference
From Quanterix Corporation
Via Business Wire
Quanterix’s Simoa® Technology Drives Advances in Alzheimer’s Disease Research Presented at 2022 Clinical Trials on Alzheimer’s Disease (CTAD) Conference
From Quanterix Corporation
Via Business Wire
Quanterix to Participate in the 15th Clinical Trials on Alzheimer’s Disease (CTAD) Task Force
From Quanterix Corporation
Via Business Wire
Quanterix to Participate in the Canaccord MedTech, Diagnostics and Digital Health & Services Forum
From Quanterix Corporation
Via Business Wire
Quanterix Corporation Releases Operating Results for Third Quarter 2022
From Quanterix Corporation
Via Business Wire
Quanterix’ Third Quarter 2022 Earnings Conference Call
From Quanterix Corporation
Via Business Wire
Quanterix Announces the Resignation of Kevin Hrusovsky as Executive Chairman of Board of Directors
From Quanterix Corporation
Via Business Wire
Quanterix Corporation Releases Operating Results for Second Quarter 2022, Announces Business Re-Alignment Plan and Revises 2022 Guidance
From Quanterix Corporation
Via Business Wire
Quanterix to Participate in the Canaccord Genuity 42nd Annual Growth Conference
From Quanterix Corporation
Via Business Wire
Quanterix’ Second Quarter 2022 Earnings Conference Call
From Quanterix Corporation
Via Business Wire
Quanterix Launches First pTau-181 Plasma Laboratory Developed Test for Clinical Diagnostic and Research Applications in the U.S.
From Quanterix Corporation
Via Business Wire
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 DalyCity.com & California Media Partners, LLC. All rights reserved.